Baloxavir marboxil, a novel cap-dependent endonuclease inhibitor potently suppresses influenza virus replication and represents therapeutic effects in both immunocompetent and immunocompromised mouse models-Reference-Cited by-同舟云学术

Baloxavir marboxil, a novel cap-dependent endonuclease inhibitor potently suppresses influenza virus replication and represents therapeutic effects in both immunocompetent and immunocompromised mouse models

Published:2019-05-20 Issue:5 Volume:14 Page:e0217307
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Fukao Keita,Ando Yoshinori,Noshi Takeshi,Kitano Mitsutaka,Noda Takahiro,Kawai Makoto,Yoshida Ryu,Sato Akihiko,Shishido Takao^ORCID,Naito Akira

Funder

Shionogi & Co. Ltd.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference35 articles.

1. The genomic and epidemiological dynamics of human influenza A virus;A Rambaut;Nature,2008

2. Influenza in immunosuppressed populations: A review of infection frequency, morbidity, mortality, and vaccine responses;KM Kunisaki;Lancet Infect Dis,2009

3. Influenza vaccination in HIV-positive subjects: latest evidence and future perspective;A Ceravolo;J Prev Med Hyg,2013

4. Seasonal influenza vaccine in immunocompromised persons;M Bosaeed;Hum Vaccin Immunother,2018

5. Mismatching between circulating strains and vaccine strains of influenza: Effect on Hajj pilgrims from both hemispheres;M Alfelali;Hum Vaccin Immunother,2016

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hydroformylation and Late-Stage Diversification on Densely Functionalized Cores of Influenza Endonuclease Inhibitors;Organic Process Research & Development;2024-08-16

2. Evaluating the Public Health and Health Economic Impacts of Baloxavir Marboxil and Oseltamivir for Influenza Pandemic Control in China: A Cost-Effectiveness Analysis Using a Linked Dynamic Transmission–Economic Evaluation Model;PharmacoEconomics;2024-07-03

3. Comparative Pathology of Animal Models for Influenza A Virus Infection;Pathogens;2023-12-29

4. A review: FDA-approved fluorine-containing small molecules from 2015 to 2022;European Journal of Medicinal Chemistry;2023-11

5. Comparison of clinical efficacy and safety of baloxavir marboxil versus oseltamivir as the treatment for influenza virus infections: A systematic review and meta-analysis;Journal of Infection and Chemotherapy;2023-10